| Today's Open | $3.03 |
|---|---|
| Previous Close | $3.06 |
| Daily Range | $2.99 - $3.05 |
| 52-Week Range | $2.26 - $5.00 |
| Market Cap | $177.7M |
| P/E Ratio | -8.50 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 147,056 |
| Average Daily Volume | 128,760 |
| Current FY EPS | -$0.37 |
Sector
Healthcare
Industry
Drugs
PLURISTEM THERAPEUTICS, INC. (PSTI) Description
Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders. Website: http://www.pluristem.com/
News & Commentary
Cloning: A Stem Cell Revolution?
Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Ce
United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial HypertensionPSTI's Top Competitors
(-0.98%)
(0.27%)
(0.59%)
(1.13%)